ArticleCancers2021

The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway.

Ana F Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.